Heidelberg-based biopharmaceutical company is conducting a follow-up study with highly purified stem cells (AMESANAR (R) ) for the treatment of previously incurable chronic ulcers.
Heidelberg, 19. October 2021 – More than 80,000 people in Germany suffer from chronic venous ulcers (CVU). Triggered by venous insufficiency, wounds and weeping ulcers can develop that may not heal for years. Severely affected patients experience intense pain every day. Until now, there has been no effective treatment – but this could change soon … read more